![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
GW Pharm. | LSE:GWP | London | Ordinary Share | GB0030544687 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 735.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMGWP RNS Number : 7995S GW Pharmaceuticals PLC 16 September 2010 +------------+---------------------+---------------------+---------------------+-----+ | | +------------------------------------------------------------------------------------+ | TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi | +------------------------------------------------------------------------------------+ | | | +--------------------------------------------------------+---------------------------+ | 1. Identity of the issuer or the underlying issuer | GW Pharmaceuticals | | of existing shares to which voting rights are | | | attached: ii | | +--------------------------------------------------------+---------------------------+ | 2 Reason for the notification (please tick the appropriate box or boxes): | +------------------------------------------------------------------------------------+ | An acquisition or disposal of voting rights | X | +------------------------------------------------------------------------------+-----+ | An acquisition or disposal of qualifying financial instruments which may | | | result in the acquisition of shares already issued to which voting rights | | | are attached | | +------------------------------------------------------------------------------+-----+ | An acquisition or disposal of instruments with similar economic effect to | | | qualifying financial instruments | | +------------------------------------------------------------------------------+-----+ | An event changing the breakdown of voting rights | | +------------------------------------------------------------------------------+-----+ | Other | | | | (please | | | | specify): | | | +------------+-----------------------------------------------------------------+-----+ | 3. Full name of person(s) | | | subject to the | M&G Investment Funds 3 | | notification obligation: iii | | +----------------------------------+-------------------------------------------------+ | 4. Full name of shareholder(s) | | | (if different from 3.):iv | | | | Nortrust Nominee Ltd A/C MKK01 | | | | | | | +----------------------------------+-------------------------------------------------+ | 5. Date of the transaction and | 14 September 2010 | | date on | | | which the threshold is crossed | | | or | | | reached: v | | +----------------------------------+-------------------------------------------------+ | 6. Date on which issuer | 15 September 2010 | | notified: | | +----------------------------------+-------------------------------------------------+ | 7. Threshold(s) that is/are | 10%-11% | | crossed or | | | reached: vi, vii | | +----------------------------------+-------------------------------------------------+ | | | | | | +------------+---------------------+---------------------+---------------------+-----+ +--------------+----------+----+------+-------+----+----+----------+----+-------+----+----------+-----+---------+----+-----+-------+ | 8. Notified details: | +----------------------------------------------------------------------------------------------------------------------------------+ | A: Voting rights attached to shares viii, ix | +----------------------------------------------------------------------------------------------------------------------------------+ | Class/type | Situation previous | Resulting situation after the triggering | | of | to the triggering | transaction | | shares | transaction | | | if | | | | possible | | | | using | | | | the ISIN | | | | CODE | | | + +----------------------------------------+--------------------------------------------------------------------------+ | | Number | Number | Number | Number of | % of voting rights x | | | of | of | of | voting | | | | Shares | Voting | shares | rights | | | | | Rights | | | | + + + +---------------+-----------------------+----------------------------------+ | | | | Direct | Direct | Indirect | Direct | Indirect | | | | | | xi | xii | | | +--------------+----------------------+-----------------+---------------+------------+----------+--------------------+-------------+ |GB0030544687 | 14,005,611 | 14,005,611 | 14,310,611 |14,310,611 | 0 | 11.02% | | +--------------+----------------------+-----------------+---------------+------------+----------+--------------------+-------------+ | | | | | | | | | +--------------+----------------------+-----------------+---------------+------------+----------+--------------------+-------------+ | | +----------------------------------------------------------------------------------------------------------------------------------+ | B: Qualifying Financial Instruments | +----------------------------------------------------------------------------------------------------------------------------------+ | Resulting situation after the triggering transaction | +----------------------------------------------------------------------------------------------------------------------------------+ | Type of financial | Expiration | Exercise/ | Number of voting | % of voting | | instrument | date xiii | Conversion Period xiv | rights that may be | rights | | | | | acquired if the | | | | | | instrument is | | | | | | exercised/ | | | | | | converted. | | +------------------------------+--------------+---------------------------------+-------------------------------+------------------+ | | | | | | +------------------------------+--------------+---------------------------------+-------------------------------+------------------+ | | +----------------------------------------------------------------------------------------------------------------------------------+ | C: Financial Instruments with similar economic effect to Qualifying Financial Instruments | | xv, xvi | +----------------------------------------------------------------------------------------------------------------------------------+ | Resulting situation after the triggering transaction | +----------------------------------------------------------------------------------------------------------------------------------+ | Type of | Exercise | Expiration | Exercise/ | Number of voting | % of voting | | financial | price | date xvii | Conversion | rights instrument | rights xix, xx | | instrument | | | period xviii | refers to | | | | | | | | | +-------------------------+-----------+------------+--------------------+-----------------------------+----------------------------+ | | | | | | Nominal | Delta | | | | | | | | | + + + + + +--------------------+-------+ | | | | | | | | +-------------------------+-----------+------------+--------------------+-----------------------------+--------------------+-------+ | | +----------------------------------------------------------------------------------------------------------------------------------+ | Total (A+B+C) | +----------------------------------------------------------------------------------------------------------------------------------+ | Number of voting rights | Percentage of voting rights | +------------------------------------------------------------------+---------------------------------------------------------------+ | 14,310,611 | 11.02% | +------------------------------------------------------------------+---------------------------------------------------------------+ | | | | | | | | | | | | | | | | | | +--------------+----------+----+------+-------+----+----+----------+----+-------+----+----------+-----+---------+----+-----+-------+ +----------------------------+-------------------------------+---------------------+ | 9. Chain of controlled undertakings through which the voting rights and/or the | | financial instruments are effectively held, if applicable: xxi | +----------------------------------------------------------------------------------+ | | +----------------------------------------------------------------------------------+ | | +----------------------------------------------------------------------------------+ | Proxy Voting: | +----------------------------------------------------------------------------------+ | 10. Name of the proxy holder: | N/A | +------------------------------------------------------------+---------------------+ | 11. Number of voting rights proxy holder will cease | N/A | | to hold: | | +------------------------------------------------------------+---------------------+ | 12. Date on which proxy holder will cease to hold | N/A | | voting rights: | | +------------------------------------------------------------+---------------------+ | | +----------------------------------------------------------------------------------+ | 13. Additional | With reference to item 3, M&G Investments Funds 3 | | information: | is an Open Ended Investment Company (OEIC) and is | | | not a Prudential group company and must be | | | separately disclosed. | | | This OEIC Fund is managed by M&G Investment | | | Management Limited (a wholly owned subsidiary of | | | Prudential plc) and will have been previously | | | attributed to Prudential plc solely on the basis | | | that M&G Investment Management Ltd has direct fund | | | management control over the shares identified in | | | this notification. | | | | | | Therefore the 11.02% holding being disclosed in | | | this notification is encompassed in the 12.18% | | | already disclosed under The Prudential plc group of | | | companies and is NOT in addition to it. | | | | +----------------------------+-----------------------------------------------------+ | 14. Contact name: | Ryan Dowling / Mark Thomas | | | M&G Investment Management Limited | +----------------------------+-----------------------------------------------------+ | 15. Contact telephone | 020 7548 2979 / 020 7548 3266 | | number: | | +----------------------------+-----------------------------------------------------+ | | | | +----------------------------+-------------------------------+---------------------+ This information is provided by RNS The company news service from the London Stock Exchange END HOLEAPNKFAXEEEF
1 Year Gw Pharmaceuticals Chart |
1 Month Gw Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions